Voleon Capital Management LP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1479847 BERKELEY, CA

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,319,419

-$1,536,215 QoQ

Shares Held

8,531

-3.9% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#380

of 1,322 holders

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 6% Shared 0% None 94%

Healthcare · as of Jun 30, 2026

Voleon Capital Management LP holds $146,865,287 across 62 Biotechnology names. REGN ranks #9 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	84,433	$20,666,665
2	EXEL	Exelixis, Inc.	251,462	$13,682,047
3	SRPT	Sarepta Therapeutics, Inc.	674,245	$12,116,182
4	BBIO	BridgeBio Pharma, Inc.	133,952	$9,976,744
5	MIRM	Mirum Pharmaceuticals, Inc.	82,877	$9,702,410
6	TVTX	Travere Therapeutics, Inc.	145,655	$8,274,660
7	CORT	Corcept Therapeutics Inc	91,926	$7,992,965
8	INBX	Inhibrx Biosciences, Inc.	58,358	$5,529,420

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,319,419	8,531	-3.9%	Shares	Sole	2026-08-14
2026-03-31	$6,855,634	8,873	-7.7%	Shares	Sole	2026-05-15
2025-12-31	$7,417,670	9,610	-62.6%	Shares	Sole	2026-02-17
2025-09-30	$14,460,459	25,718	+37.8%	Shares	Sole	2025-11-14
2025-06-30	$9,798,075	18,663	+1400.2%	Shares	Sole	2025-08-14
2025-03-31	$788,982	1,244	+85.4%	Shares	Sole	2025-05-16
2024-12-31	$477,973	671	-98.4%	Shares	Sole	2025-02-14
2020-12-31	$20,049,065	41,500	0.0%	Shares	Sole	2021-02-16
2020-09-30	$23,230,870	41,500	0.0%	Shares	Sole	2020-11-16
2020-06-30	$25,881,475	41,500	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.